Payer: Page 84


  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Culling surprise billing would save $40B annually, Health Affairs study finds

    The research also found that out-of-network billing was most common at for-profit hospitals and in areas with highly concentrated provider and payer markets.

    By Dec. 16, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    BCBS of Michigan cuts new value payment deal with 7 major systems

    The model will apply to roughly 30% of the payer's total commercial and Medicare Advantage market. Health systems that have signed on include Ascension Michigan, Henry Ford Health System and Trinity Health.

    By Dec. 16, 2019
  • Explore the Trendline
    Image attribution tooltip
    Yujin Kim/Healthcare Dive
    Image attribution tooltip
    Trendline

    Payer/provider relationships

    As M&A intensifies and companies embrace more holistic and value-based care models, partnerships have become more closely intertwined.

    By Healthcare Dive staff
  • Image attribution tooltip
    Humana
    Image attribution tooltip

    Humana to acquire hospice pharmacy, PBM Enclara

    The Louisville, Kentucky-based payer is looking to round out its pharmacy offerings for high-need patients.

    By Dec. 16, 2019
  • HHS watchdog accuses MA plans of inflating payments by nearly $7B annually

    The apparent overpayments are tied to payers tacking on new diagnosis codes as part of a review of existing medical charts, a practice CMS is encouraged to watch more closely.

    By Ron Shinkman • Dec. 13, 2019
  • Image attribution tooltip
    Express Scripts Holding Co.
    Image attribution tooltip

    Livongo, Propeller, Omada tapped for Express Scripts digital health formulary

    The PBM presented the formulary as a way for health plans and employers to access digital health products that have been vetted for effectiveness, security and value.

    By Nick Paul Taylor • Dec. 13, 2019
  • Centene's headquarters in Clayton, Missouri, a suburb outside of St. Louis.
    Image attribution tooltip
    Samantha Liss/Healthcare Dive
    Image attribution tooltip

    Centene quietly lobbying Congress to let states partially expand Medicaid

    Centene wants to lower the eligibility on Medicaid expansion populations from 138% to 100% of the federal poverty level, ultimately pushing more people into the ACA exchanges. 

    By Dec. 12, 2019
  • Amid legal roadblocks, CMS clears South Carolina Medicaid work mandates

    The administration has approved work requirements in ten states so far, though three (New Hampshire, Kentucky and Arkansas) have seen their programs struck down by a federal judge.

    By Dec. 12, 2019
  • Image attribution tooltip
    Getty / Edited by BioPharma Dive
    Image attribution tooltip

    Value-based pricing for gene therapy? Maybe not ready for hemophilia

    Small patient population plus large potential savings could make blood clotting gene therapies an easier sell to payers, biotech execs say.

    By Jonathan Gardner • Dec. 12, 2019
  • CVS launches precision medicine program for oncology

    Executives have teased a cancer care pilot for much of this year as they look for ways to capitalize on overlap between retail locations and Aetna. 

    By Dec. 12, 2019
  • Image attribution tooltip
    Dollar Photo Club
    Image attribution tooltip

    Health insurers stable, M&A seen diminishing in 2020: Fitch

    Despite a projected increase in the growth of U.S. health spending, the ratings agency expects insurers to deliver healthy operating results including improved medical loss ratios for 2020.

    By Dec. 11, 2019
  • Image attribution tooltip
    PillPack
    Image attribution tooltip

    Amazon's PillPack inks 1st digital pact with payer in BCBS Massachusetts

    The Blues plan will target the offering to the 12% of its beneficiaries that take five or more maintenance medications, and the 43% that take between two and four, a spokesperson told Healthcare Dive.

    By Dec. 11, 2019
  • Kaiser interim chief Greg Adams named full-time CEO

    Adams has been at the nonprofit for over two decades and previously served as a group president overseeing hospital and health plan operations, including Kaiser's Medicare care delivery strategy.

    By Dec. 11, 2019
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Few Medicare Advantage plans add new benefits for serious illness

    Starting this year, CMS gave the plans flexibility to offer more benefits for nonmedical services like home-based palliative care, adult daycare services, bathroom safety devices and modifications.

    By Linda Wilson • Dec. 11, 2019
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Health insurance coverage linked to reduced mortality

    In a sweeping study of millions of households, researchers found that people were more likely to sign up for health insurance once prodded.

    By Dec. 10, 2019
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Surprise billing ban draft: Middle ground leaves few pleased

    The bill backed by a bipartisan group of Senate and House leadership would require insurers pay at least the median in-network negotiated rate for the area market for out-of-network services and has an arbitration backstop.

    By Dec. 10, 2019
  • Competing House surprise billing plan muddies path of White House-backed legislation

    The House Ways and Means Committee unveiled its own surprise billing legislation Wednesday that relies on arbitration.

    By Updated Dec. 12, 2019
  • Image attribution tooltip
    UnitedHealth Group
    Image attribution tooltip

    UnitedHealth to acquire embattled specialty pharmacy Diplomat for $300M

    Four separate lawsuits are attempting to enjoin the purchase, the payer said this week. The cases allege information about the deal was held back from Diplomat shareholders, including financial data.

    By Updated Jan. 24, 2020
  • Centene's headquarters in Clayton, Missouri, a suburb outside of St. Louis.
    Image attribution tooltip
    Samantha Liss/Healthcare Dive
    Image attribution tooltip
    Dive Awards

    Payer of the Year: Centene

    Centene's blockbuster acquisition of WellCare doubled its Medicare Advantage footprint and positions the company to be the leader of government-sponsored plans.

    By Dec. 9, 2019
  • Image attribution tooltip
    CVS Health
    Image attribution tooltip
    Dive Awards

    Executive of the Year: Larry Merlo, CVS Health

    Merlo has a vision for the future of the industry, and he's leveraging all of the retail giant's many assets to try and get there.​

    By Dec. 9, 2019
  • Image attribution tooltip
    Yujin Kim/Healthcare Dive
    Image attribution tooltip
    Dive Awards

    The Healthcare Dive Awards for 2019

    From the Affordable Care Act lawsuit to CVS Health CEO Larry Merlo, these are the companies, executives and movements that shaped U.S. healthcare this year.

    Dec. 9, 2019
  • Value-based care payments increasing but risk still rare

    Bundled payment adoption, for example, remained flat between 2012 and 2017 despite studies showing their promise in holding down costs, the Catalyst for Payment Reform found.

    By Ron Shinkman • Dec. 6, 2019
  • More than 1K employers push Senate to repeal ACA Cadillac tax

    AHIP and the U.S. Chamber of Commerce were among those arguing the tax will have sweeping effects beyond just "gold-plated" health coverage and will raise costs for the millions of Americans with employer coverage.

    By Dec. 6, 2019
  • US healthcare spending growth rebounded last year, influenced by insurance tax

    Hospital and physician and clinical services spending fell, but prices were up. CMS Administrator Seema Verma blamed provider consolidation and the "creation of monopolies."

    By Dec. 5, 2019
  • Image attribution tooltip
    CMS
    Image attribution tooltip

    Medicare Advantage members rarely review or switch plans

    A Kaiser Family Foundation analysis found that more than one in three Medicare beneficiaries reported difficulty comparing plan options and nearly half of those on Medicare said they rarely or never review their choices.

    By Dec. 4, 2019
  • Image attribution tooltip
    Lydia Polimeni, National Institutes of Health
    Image attribution tooltip
    Deep Dive

    Will sky-high drug prices spur the US to use an obscure power over patents?

    New cell therapies as well as gene-based treatments like Zolgensma benefited from NIH funding of early-stage research. Advocates say the time is now for the government to invoke its "march-in" rights. 

    By Jonathan Gardner • Dec. 4, 2019